Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-60.06	10.91	27.31
Graham Fair Price	71.43	0.34	0.20
PEG	-71.82	0.06	-0.22
Price/Book	-4.21	2.54	2.65
Price/Cash Flow	-31.96	205.08	301.42
Prices/Earnings	-67.39	12.19	37.38
Price/Sales	-52.11	4.11	8.57
Price/FCF	-31.96	205.08	301.42
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-33.73	0.30	0.46
Operating Margin	6.84	0.30	0.28
ROA	193.76	0.04	0.01
ROE	0.02	0.05	193.76
ROIC	0.03	0.08	146.50
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.84	0.08	992.73
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	3.96	1.14	-71.33
EPS QOQ	1.67	1.93	15.71
FCF QOQ	-0.87	0.41	-52.87
Revenue QOQ	-0.26	1.00	282.92
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1.78	0.09	-95.15
Days Sales Outstanding (DSO)	118.95	61.38	-48.40
Inventory Turnover	50.46	1040.52	1961.94
Debt/Capitalization	0.04	0.08	77.73
Quick Ratio	2.71	2.76	2.01
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.32	0.32	0.02
Cash	0.08	0.08	0.02
Capex	< 0.005	< 0.005	-164.80
Free Cash Flow	< 0.005	< 0.005	40.81
Revenue	0.10	0.19	100.04
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.85	2.85	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.19	-0.73	66.88
Naive Interpretation	Member

06 - Financial Health · Bad

Rating